Stephen J. Ganocy, PhD

Stephen J. Ganocy, PhD

Director, Data Management & Statistical Analysis Unit
Bipolar Disorders Research Center
University Hospitals Cleveland Medical Center
Case Western Reserve University
Phone: 216-844-2853 | Fax: 216-844-2875


Research Interests

Application of Statistics to Medical Psychiatry

Selected Publications

  1. Calabrese JR, Prescott M, Tamburrino M, Liberzon I, Slembarski R, Goldmann E, Shirley E, Fine T, Goto T, Wilson K, Ganocy SJ, Chan P, Serrano MB, Sizemore J, Galea S. PTSD comorbidity and suicidal ideation associated with PTSD within the Ohio army national guard. J Clin Psychiatry. 2011;72(8):1072-78.
  2. Kemp DE, Gao K, Fein EB, Chan PK, Conroy C, Obral S, Ganocy SJ, Calabrese JR. Lamotrigine as add-on treatment to lithium and divalproex: Lessons learned from a double-blind, placebo-controlled trial in rapid-cycling bipolar disorder. Bipolar Disord. 2012; 14(7):780-9.
  3. Arnold LE, Ganocy SJ, Mount K, Youngstrom EA, Frazier T, Fristad M, Horwitz SM, Birmaher B, Findling R, Kowatch RA, Demeter C, Axelson D, Gill MK, Marsh L. Three-year latent class trajectories of ADHD symptoms in a clinical sample not selected for ADHD. J Am Acad Child Adolesc Psychiatry 2014;53(7):745-60.
  4. Gao K, Chen, J, Wu R, Wang Z, Ren M, Kemp DE, Chan PK, Conroy CM, Serrano MB, Ganocy SJ, Calabrese JR: Disagreement between self-reported and clinician-ascertained suicidal ideation and its correlation with depression and anxiety severity in patients with major depressive disorder or bipolar disorder. J Psych Res. 2015; 60:117-124.
  5. Ganocy SJ, Goto T, Chan PK, Cohen GH, Sampson L, Galea S, Liberzon I, Fine T, Shirley E, Sizemore J, Calabrese JR, Tamburrino MB: Association of spirituality with mental health conditions in Ohio National Guard soldiers. J Nerv Ment Dis. 2016;204(7):524-9.
  6. Gao K, Goto T, Yuan C, Brownrigg B, Conroy C, Chan PK, Serrano MB, Ganocy S, Fang F, Calabrese JR: A pilot study of the effectiveness of lithium versus Quetiapine immediate release monotherapy in patients with bipolar spectrum disorders. J Clin Psychopharmacol, 2018;39(5):422-434.
  7. Aftab A, Kemp DE, Ganocy SJ, Schinagle M, Conroy C, Brownrigg B, D'Arcangelo N, Goto T, Woods N, Serrano MB, Han H, Calabrese JR, Gao K: Double-blind, placebo-controlled trial of Pioglitazone for bipolar depression. J Affect Disord. 2019;245(2):957-964.